Cleveland BioLabs
CBLI
#9245
Rank
HK$0.38 B
Marketcap
HK$24.64
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Revenue for Cleveland BioLabs (CBLI)

Revenue in 2020 (TTM): HK$4.91 Million

According to Cleveland BioLabs 's latest financial reports the company's current revenue is HK$4.91 Million. In 2019 the company made a revenue of HK$8.65 Million a decrease over the revenue in the year 2018 that were of HK$8.84 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cleveland BioLabs from 2004 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)HK$4.91 M-43.24%
2019HK$8.65 M-2.18%
2018HK$8.84 M-41.58%
2017HK$15.14 M-44.62%
2016HK$27.34 M29.92%
2015HK$21.04 M-26.84%
2014HK$28.77 M-56.39%
2013HK$65.96 M137.71%
2012HK$27.75 M-59.38%
2011HK$68.31 M-42.67%
2010HK$0.11 B6.87%
2009HK$0.11 B204.87%
2008HK$36.57 M133.12%
2007HK$15.68 M18.17%
2006HK$13.27 M50%
2005HK$8.85 M78.97%
2004HK$4.94 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
HK$1.75 M-64.23%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$5.56 B 113,278.19%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$252.84 B 5,148,972.08%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$388.12 B 7,903,774.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
HK$368.65 B 7,507,314.83%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$415.84 B 8,468,336.48%๐Ÿ‡ซ๐Ÿ‡ท France
HK$312.83 B 6,370,591.80%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$0.9 M-81.48%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$317.58 B 6,467,228.86%๐Ÿ‡บ๐Ÿ‡ธ USA